Login / Signup

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.

Sophie I E LiemSam NeppelenbroekCynthia M FehresBrigitte A WeversRené E M ToesCornelia F AllaartThomas Wj HuizingaHans Ulrich SchererJeska K De Vries-Bouwstra
Published in: RMD open (2023)
Although a role of ATA in disease progression is suggested, more studies on the ATA response in suspected very early SSc are warranted.
Keyphrases
  • systemic sclerosis
  • interstitial lung disease
  • pulmonary embolism
  • case control
  • idiopathic pulmonary fibrosis